Attila Fejer – General Manager, Eli Lilly Romania
Attila Fejer general manager of Eli Lilly in Romania gives his insights on the “deadly cocktail” of challenging policies that govern the pharmaceutical industry in the country. He shares the…
Address: Bucharest Business Park (BBP), Str. Menuetului nr. 12, corp D, Et.2, sector 1, cod 013681, Bucuresti, Romania
Tel: 021.402.30.00
Web: http://www.lilly.com/Pages/home.aspx
Eli Lilly Worldwide
• Headquarters located at Indianapolis, Indiana, U.S.A.
• Approximately 40 thousand employees worldwide
• Approximately 8 thousand employees engaged in research and development
• Clinical research conducted in more than 50 countries
• Research and development facilities located in 8 countries
• Manufacturing plants located in 13 countries
• Products marketed in 143 countries
• Net Sales of US $ 21.8 billions for 2009
• R&D expenditure: approx 20% of Sales
Eli Lilly began operations in Romania in the 1990s.
Worldwide, Lilly´s medicines are currently treating schizophrenia, diabetes, bipolar disorder, stress urinary incontinence, erectile dysfunction, depression, cancer, heart disease, pain, infections and gastric disorders and bringing relief to millions of people.
Attila Fejer general manager of Eli Lilly in Romania gives his insights on the “deadly cocktail” of challenging policies that govern the pharmaceutical industry in the country. He shares the…
You have just arrived as general manager in January 2011. Coming to a new market obviously means a new context, different challenges and so on. Can you first elaborate on…
PharmaBoardroom takes a look at the careers of five pharma executives who we spoke to as Romania country managers back in 2015. At the end of 2019, all of them…
Here we highlight five of the most important women working in healthcare and the life sciences in Central & Eastern Europe (CEE) today. From regulators to pharma affiliate heads with…
Multinationals have struggled to adapt their Romanian strategies, but the local production sector appears to be flourishing. Much of this impetus relates directly to EU accession and the harmonization of…
No one can accuse the Romanian government of being lethargic when it comes to healthcare reform. After an unprecedented seven years of zero new molecules being admitted to the state…
Once touted by the IMS as one of the “fast followers” among the world’s “pharmerging” nations and feted by the international investor community in the wake of EU accession, Romania’s…
Raed Arafat, Secretary of State at the Romanian Ministry of Internal Affairs highlights the key trends in Romanian healthcare over recent years, his own role in reforming the country’s healthcare…
The managing partner of a specialist boutique PR and integrated communications management agency serving the local pharma sector unveils his theory of holistic, industry-wide lobbying and gives some pointers as…
The general manager of a British pharma giant with over 25 years of presence in Romania discusses how vaccination programs can play a significant role in increasing the cost-effectiveness of the…
The directors of one of the leading in country contract research organisations, explain exactly what makes Romania such an attractive destination for clinical trials. They also give some indications of…
The directors of one of the leading in country contract research organisations, explain exactly what makes Romania such an attractive destination for clinical trials. They also give some indications of…
The general manager of one of the leading CROs in Romania explains how the country in gathering pace as a top tier clinical trials destination country within the region and…
The country manager of one of the foremost providers of sustainable and integrated healthcare solutions describes the sorts of local adaptations that need to be enacted when launching a product on the…
See our Cookie Privacy Policy Here